INVO 0.82 INVO Bioscience, Inc.
| Range: | 0.52-3.5 | Vol Avg: | 1139398 | Last Div: | 0 | Changes: | -0.04 |
| Beta: | 1.44 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Mon Nov 02 2020 | Empoloyees: | 25 | ||
| CUSIP: | 44984F302 | CIK: | 0001417926 | ISIN: | US44984F4019 | Country: | US |
| CEO: | Mr. Steven M. Shum | Website: | https://www.invobio.com | ||||
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow